Document Type : Review Article


1 Master of Science in Cellular and Molecular Biology, Department of cell and Molecular Biology, Karazmi University, Tehran, Iran

2 School of Paramedical Sciences, Iran University of Medical Sciences, Tehran, Iran


Cancer is largely a disease of older people; the median age for cancer diagnosis in industrialised countries is approaching 70 years of age and is expected to increase. The morbidity and mortality rates of various tumors increase with age, and thus, malignant tumors are generally defined as aging diseases. The immune system has an ambiguous role in cancer, as it plays an important immune surveillance role in the antitumor response but is also closely associated with the initiation and progression of tumors. With aging we assist to the erosion of the immune response called immunosenescence. This deregulation particularly affects the T cell compartment of the adaptive immune response. In addition to the accumulation of genetic mutations, many researchers believe that immunosenescence may also play an important role in
the tumoral process. In the future, targeting immune senescent cells may be a novel interventional opportunity in cancer patients.


1.Gloeckler Ries LA, Reichman ME, Lewis DR, Hankey BF,
Edwards BK. Cancer survival and incidence from the
Surveillance, Epidemiology, and End Results (SEER) program.
The oncologist. 2003 Dec;8(6):541-52.
2.Muñoz-Espín D, Serrano M. Cellular senescence: from physiology
to pathology. Nature reviews Molecular cell biology. 2014
3.Gorgoulis V, Adams PD, Alimonti A, Bennett DC, Bischof O,
Bishop C, Campisi J, Collado M, Evangelou K, Ferbeyre G, Gil
J. Cellular senescence: defining a path forward. Cell. 2019 Oct
4.Yang L, Li A, Lei Q, Zhang Y. Tumor-intrinsic signaling pathways:
key roles in the regulation of the immunosuppressive tumor
microenvironment. Journal of hematology & oncology. 2019
5.Pawelec G. Immunosenescence comes of age: symposium on aging
research in immunology: the impact of genomics.
6.Caruso C, Accardi G, Virruso C, Candore G. Sex, gender and
immunosenescence: a key to understand the different lifespan
between men and women?.
7.Ponnappan S, Ponnappan U. Aging and immune function:
molecular mechanisms to interventions.
8.Su DM, Aw D, Palmer DB. Immunosenescence: a product of
the environment?. Current opinion in immunology. 2013 Aug
9.Nikolich-Žugich J. The twilight of immunity: emerging concepts
in aging of the immune system. Nature immunology. 2018
10.Pinti M, Appay V, Campisi J, Frasca D, Fülöp T, Sauce D, Larbi
A, Weinberger B, Cossarizza A. Aging of the immune system:
focus on inflammation and vaccination. European journal of
immunology. 2016 Oct;46(10):2286-301.
11.Candore G, Balistreri CR, Listi F, Grimaldi MP, Vasto S,
COLONNA‐ROMANO GI, Franceschi C, Lio D, Caselli G,
Caruso C. Immunogenetics, gender, and longevity. Annals of the
New York Academy of Sciences. 2006 Nov;1089(1):516-37.
12.Derhovanessian E, Maier AB, Beck R, Jahn G, Hähnel K,
Slagboom PE, De Craen AJ, Westendorp RG, Pawelec
G. Hallmark features of immunosenescence are absent in
familial longevity. The Journal of Immunology. 2010 Oct
13.Schreiber TH, Podack ER. A critical analysis of the tumour
immunosurveillance controversy for 3-MCA-induced sarcomas.
British journal of cancer. 2009 Aug;101(3):381-6.
14.Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can
be a temporal bridge between a CD4+ T-helper and a T-killer
cell. Nature. 1998 Jun;393(6684):474-8.
15.Corthay A, Skovseth DK, Lundin KU, Røsjø E, Omholt H,
Hofgaard PO, Haraldsen G, Bogen B. Primary antitumor
immune response mediated by CD4+ T cells. Immunity. 2005
Mar 1;22(3):371-83.
16. Nakamura H, Saji H, Ogata A, Hosaka M, Hagiwara M,
Kawasaki N, Konaka C, Kato H. Immunologic parameters as
significant prognostic factors in lung cancer. Lung Cancer. 2002
Aug 1;37(2):161-9.
17.Unitt E, Marshall A, Gelson W, Rushbrook SM, Davies S, Vowler
SL, Morris LS, Coleman N, Alexander GJ. Tumour lymphocytic
infiltrate and recurrence of hepatocellular carcinoma following
liver transplantation. Journal of hepatology. 2006 Aug
18.Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ,
Schreiber RD. IFNγ and lymphocytes prevent primary tumour
development and shape tumour immunogenicity. Nature. 2001
19.Bourée P. Immunity and immunization in elderly. Pathologie
Biologie. 2003 Dec 1;51(10):581-5.
20.Yehuda AB, Friedman G, Wirtheim E, Abel L, Globerson A.
Checkpoints in thymocytopoiesis in aging: expression of the
recombination activating genes RAG-1 and RAG-2. Mechanisms
of ageing and development. 1998 May 15;102(2-3):239-47.
21.López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G.
The hallmarks of aging. Cell. 2013 Jun 6;153(6):1194-217.
22.Chen W, Zheng R, Zhang S, Zeng H, Zuo T, Xia C, Yang Z, He
J. Cancer incidence and mortality in China in 2013: an analysis
based on urbanization level. Chinese Journal of Cancer Research.
2017 Feb;29(1):1.
23.Hong H, Wang Q, Li J, Liu H, Meng X, Zhang H. Aging, cancer
and immunity. Journal of Cancer. 2019;10(13):3021.
24.Kendal WS. Dying with cancer: the influence of age, comorbidity,
and cancer site. Cancer: Interdisciplinary International Journal
of the American Cancer Society. 2008 Mar 15;112(6):1354-62.
25.Castelo-Branco C, Soveral I. The immune system and aging: a
review. Gynecological Endocrinology. 2014 Jan 1;30(1):16-22.
26.Zgibor JC, Ye L, Boudreau RM, Conroy MB, Vander Bilt J,
Rodgers EA, Schlenk EA, Jacob ME, Brandenstein J, Albert SM,
Newman AB. Community-based healthy aging interventions
for older adults with arthritis and multimorbidity. Journal of
community health. 2017 Apr 1;42(2):390-9.
27.Besser MJ, Shapira-Frommer R, Treves AJ, Zippel D, Itzhaki O,
Hershkovitz L, Levy D, Kubi A, Hovav E, Chermoshniuk N,
Shalmon B. Clinical responses in a phase II study using adoptive
transfer of short-term cultured tumor infiltration lymphocytes in
metastatic melanoma patients. Clinical cancer research. 2010
May 1;16(9):2646-55.
28.Kochenderfer JN, Wilson WH, Janik JE, Dudley ME, Stetler-
Stevenson M, Feldman SA, Maric I, Raffeld M, Nathan DA,
Lanier BJ, Morgan RA. Eradication of B-lineage cells and
regression of lymphoma in a patient treated with autologous
T cells genetically engineered to recognize CD19. Blood, The
Journal of the American Society of Hematology. 2010 Nov
29.Kelland L. Discontinued drugs in 2005: oncology drugs. Expert
opinion on investigational drugs. 2006 Nov 1;15(11):1309-18.
30.Leach DR, Krummel MF, Allison JP. Enhancement of
antitumor immunity by CTLA-4 blockade. Science. 1996 Mar
31.Auerbach R, Kubai L, Sidky Y. Angiogenesis induction by tumors,embryonic tissues, and lymphocytes. Cancer Research. 1976 Sep
1;36(9 Part 2):3435-40.
32.Franceschi S. LA Vecchia C: Cancer epidemiology in the elderly.
Critical Rev Oncol Hematol. 2001;39:219-26.
33.DeSantis CE, Miller KD, Dale W, Mohile SG, Cohen HJ, Leach
CR, Sauer AG, Jemal A, Siegel RL. Cancer statistics for adults
aged 85 years and older, 2019. CA: a cancer journal for clinicians.
2019 Nov 1;69(6):452-67.
34.Palmer S, Albergante L, Blackburn CC, Newman TJ. Thymic
involution and rising disease incidence with age. Proceedings of
the National Academy of Sciences. 2018 Feb 20;115(8):1883-8.
35.Malaguarnera L, Ferlito L, Di Mauro S, Imbesi RM, Scalia G,
Malaguarnera M. Immunosenescence and cancer: a review.
Archives of gerontology and geriatrics. 2001 Mar 1;32(2):77-93.
36.Derhovanessian E, Solana R, Larbi A, Pawelec G. Immunity,
ageing and cancer. Immunity & Ageing. 2008 Dec;5(1):1-6.
37.Fulop T, Kotb R, Fortin CF, Pawelec G, De Angelis F, Larbi A.
Potential role of immunosenescence in cancer development.
Annals of the New York Academy of Sciences. 2010
38.Gravekamp C, Kim SH, Castro F. Cancer vaccination:
manipulation of immune responses at old age. Mechanisms of
ageing and development. 2009 Jan 1;130(1-2):67-75.
39.Huang H, Patel DD, Manton KG. The immune system in aging:
roles of cytokines, T cells and NK cells. Front Biosci. 2005 Jan
40.Lustgarten J. Cancer, aging and immunotherapy: lessons learned
from animal models. Cancer Immunology, Immunotherapy.
2009 Dec 1;58(12):1979.
41.Serrano M, Blasco MA. Cancer and ageing: convergent and
divergent mechanisms. Nature reviews Molecular cell biology.
2007 Sep;8(9):715-22.
42.Finn OJ. Human tumor antigens, immunosurveillance, and cancer
vaccines. Immunologic research. 2006 Sep;36(1):73-82.
43.Davis MM. A prescription for human immunology. Immunity.
2008 Dec 19;29(6):835-8.
44.Alpert A, Pickman Y, Leipold M, Rosenberg-Hasson Y, Ji X,
Gaujoux R, Rabani H, Starosvetsky E, Kveler K, Schaffert
S, Furman D. A clinically meaningful metric of immune age
derived from high-dimensional longitudinal monitoring. Nature
medicine. 2019 Mar;25(3):487-95.